Patrik Dahlen

Patrik Dahlen is an accomplished executive with extensive experience in the biotechnology and diagnostics sectors. Currently serving as Chief Executive Officer of Immudex since November 2022, Dahlen has held significant leadership roles including CEO and Board Member for SSI Diagnostica since October 2016, contributing to its prominence as a leading microbiology company in the Nordic countries. Dahlen's tenure also includes positions as Chairman of the Board of Directors at Visiopharm, where a focus on digital pathology aims to enhance diagnostic capabilities, and EuropaBiosite, where strategic transformations were facilitated leading to a successful exit to EQT. Additional past roles include Chairmanship at Advalight and leadership positions at Immunovia AB and NeuroSearch, complemented by a strong educational background with MSc and PhD degrees in Biochemistry from Åbo Akademi University and Turku University.